Bull case
ADM would need investors to value it at roughly 41x earnings — about 25x more generous than today's 16x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where ADM stock could go
ADM would need investors to value it at roughly 41x earnings — about 25x more generous than today's 16x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 31x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
The bear case assumes sentiment or fundamentals disappoint enough to push ADM down roughly 20% from the current price.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Archer-Daniels-Midland is a global agricultural processor and commodity trader that transforms crops like oilseeds, corn, and wheat into food ingredients, animal feed, and industrial products. It makes money through three main segments: Ag Services and Oilseeds (~60% of revenue), Carbohydrate Solutions (~25%), and Nutrition (~15%), with profits coming from processing margins, trading spreads, and value-added ingredient sales. The company's key advantage is its massive global logistics network—including storage, transportation, and processing facilities—that creates significant economies of scale and market access.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $0.93/$0.82 | +13.8% | $21.2B/$22.0B | -3.8% |
| Q4 2025 | $0.92/$0.85 | +8.4% | $20.4B/$20.8B | -1.9% |
| Q1 2026 | $0.87/$0.80 | +9.2% | $18.6B/$21.1B | -11.9% |
| Q2 2026 | $0.71/$0.64 | +10.8% | $20.5B/$21.4B | -4.0% |
ADM beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $57 — implies -23.7% from today's price.
| Metric | ADM | S&P 500 | Consumer Defensive | 5Y Avg ADM |
|---|---|---|---|---|
| Forward PE | 16.2x | 18.8x-14% | 14.2x+14% | — |
| Trailing PE | 33.7x | 24.4x+38% | 18.9x+78% | 15.4x+119% |
| PEG Ratio | — | 1.66x | 1.92x | — |
| EV/EBITDA | 16.7x | 15.2x+10% | 11.1x+51% | 11.5x+45% |
| Price/FCF | 8.6x | 20.7x-58% | 15.3x-44% | 14.3x-40% |
| Price/Sales | 0.5x | 3.1x-85% | 0.9x-49% | 0.4x+12% |
| Dividend Yield | 2.72% | 1.91% | 3.06% | 2.78% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolADM returns 2.7% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~1.5 years to full repayment at current FCF run-rate
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 18, 2026
ADM and former executives were charged by the SEC for materially inflating the performance of its Nutrition segment, misleading investors.
ADM was fined $40M in a price-fixing probe, indicating historical issues with corporate governance and compliance.
Morgan Stanley cited weakening margins in ADM's Carbohydrate Solutions unit and repeated cuts to its 2025 profit outlook.
ADM faces risks from regulatory delays and uncertainty in biofuel policies, impacting profitability.
Trade disruptions are contributing to softer agricultural services and oilseed profits, affecting overall performance.
Analyst downgrades and negative sentiment may weigh on ADM's stock performance in the near term.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 18, 2026
Archer-Daniels-Midland reported fourth-quarter 2025 results that exceeded earnings estimates and raised its quarterly dividend by 2%, signaling financial strength.
Analysts have lifted full-year earnings estimates for Archer-Daniels-Midland, reflecting a stronger earnings outlook compared to earlier expectations.
ADM operates a vast global network with over 800 facilities across more than 200 countries, providing significant market reach and operational resilience.
As one of the world's largest agricultural commodities processors and trading companies, ADM benefits from its dominant position in the industry.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
ADM ADM Archer-Daniels-Midland Company | $36.2B | 16.2x | +1.4% | 1.3% | Hold | +0.2% |
BG BG Bunge Global S.A. | $21.8B | 12.1x | +10.5% | 0.9% | Buy | +18.7% |
ING INGR Ingredion Incorporated | $6.2B | 9.1x | +1.0% | 10.1% | Hold | +19.5% |
TSN TSN Tyson Foods, Inc. | $19.7B | 13.7x | +4.0% | 0.8% | Buy | +34.3% |
CAG CAG Conagra Brands, Inc. | $6.3B | 7.8x | +0.4% | 0.1% | Hold | +15.2% |
CAL CALM Cal-Maine Foods, Inc. | $3.7B | 9.8x | +9.0% | 27.4% | Hold | +15.8% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
ADM returns 2.7% total yield, led by a 2.72% dividend, raised 28 consecutive years.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $1.04 | — | — | — |
| 2025 | $2.04 | +2.0% | 0.0% | 3.5% |
| 2024 | $2.00 | +11.1% | 9.3% | 13.3% |
| 2023 | $1.80 | +12.5% | 6.8% | 9.3% |
| 2022 | $1.60 | +8.1% | 2.8% | 4.5% |
Common questions answered from live analyst data and company financials.
Archer-Daniels-Midland Company (ADM) is rated Hold by Wall Street analysts as of 2026. Of 36 analysts covering the stock, 12 rate it Buy or Strong Buy, 21 rate it Hold, and 3 rate it Sell or Strong Sell. The consensus 12-month price target is $75, implying +0.2% from the current price of $75. The bear case scenario is $90 and the bull case is $189.
The Wall Street consensus price target for ADM is $75 based on 36 analyst estimates. The high-end target is $95 (+26.5% from today), and the low-end target is $58 (-22.8%). The base case model target is $143.
ADM trades at 16.2x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals expensive versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for ADM in 2026 are: (1) Regulatory Violations — ADM and former executives were charged by the SEC for materially inflating the performance of its Nutrition segment, misleading investors. (2) Financial Misconduct — ADM was fined $40M in a price-fixing probe, indicating historical issues with corporate governance and compliance. (3) Margin Pressure — Morgan Stanley cited weakening margins in ADM's Carbohydrate Solutions unit and repeated cuts to its 2025 profit outlook. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates ADM will report consensus revenue of $81.7B (+1.4% year-over-year) and EPS of $3.26 (+45.8% year-over-year) for the upcoming fiscal year. The following year, analysts project $84.2B in revenue.
Archer-Daniels-Midland Company is expected to report its next earnings on approximately 2026-08-04. Consensus expects EPS of $1.41 and revenue of $22.8B. Over recent quarters, ADM has beaten EPS estimates 67% of the time.
Archer-Daniels-Midland Company (ADM) generated $4.8B in free cash flow over the trailing twelve months — a free cash flow margin of 6.0%. ADM returns capital to shareholders through dividends (2.7% yield) and share repurchases ($0 TTM).